キャリアスクリーニング市場規模、シェア、成長分析、検査タイプ別、疾患タイプ別、病状別、技術別、エンドユーザー別、地域別 - 産業予測、2025-2032年

キャリアスクリーニングの世界市場規模は2023年に25億米ドルと評価され、2024年の28億3,000万米ドルから2032年には76億3,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは13.2％で成長する見通しです。

世界のキャリアスクリーニング市場は、遺伝性疾患の罹患率の上昇と予防ヘルスケアへの注目の高まりに牽引され、成長が見込まれています。ゲノム技術の進歩や、嚢胞性線維症、テイサックス、鎌状赤血球貧血などの疾患に対する意識の高まりにより、今後数年間でキャリアスクリーニングの採用が進むと予想されます。さらに、遺伝子検査へのアクセスが改善され、有利な償還政策が業界関係者に新たな機会をもたらしています。しかし、標準化の欠如、新興市場における認知度の低さ、結果の解釈の複雑さ、高度な検査技術に伴う高コストといった課題は、2031年にむけて市場拡大を妨げる可能性があります。全体として、この状況は技術革新の機が熟していますが、利害関係者は成長機会を生かすためにこれらのハードルを乗り越えなければなりません。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

キャリアスクリーニング市場規模：検査タイプ別

• 市場概要
• 分子スクリーニング検査
• 生化学スクリーニング検査

キャリアスクリーニング市場規模：疾患タイプ別

• 市場概要
• 嚢胞性線維症
• テイ・サックス病
• ゴーシェ病
• 鎌状赤血球症
• 脊髄性筋萎縮症
• その他の常染色体劣性遺伝性疾患

キャリアスクリーニング市場規模：病状別

• 市場概要
• 肺疾患
• 血液疾患
• 神経疾患
• その他

キャリアスクリーニング市場規模：技術別

• 市場概要
• DNA配列解析
• ポリメラーゼ連鎖反応
• マイクロアレイ
• その他

キャリアスクリーニング市場規模：エンドユーザー別

• 市場概要
• 病院
• リファレンスラボ
• 医院、診療所
• その他

キャリアスクリーニング市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Illumina, Inc.（USA）
• Thermo Fisher Scientific Inc.（USA）
• Natera, Inc.（USA）
• Myriad Genetics, Inc.（USA）
• Eurofins Scientific（Luxembourg）
• Laboratory Corporation of America Holdings（LabCorp）（USA）
• Quest Diagnostics Incorporated（USA）
• Invitae Corporation（USA）
• PerkinElmer, Inc.（USA）
• Fulgent Genetics（USA）
• Agilent Technologies, Inc.（USA）
• Genomics England（UK）
• Centogene AG（Germany）
• Integrated DNA Technologies, Inc.（IDT）（USA）
• BGI Genomics（China）
• Ambry Genetics Corporation（USA）
• DNA Genotek Inc.（Canada）
• GeneDx, Inc.（USA）
• MedGenome Labs Pvt. Ltd.（India）

結論と提言

Global Carrier Screening Market size was valued at USD 2.5 billion in 2023 and is poised to grow from USD 2.83 billion in 2024 to USD 7.63 billion by 2032, growing at a CAGR of 13.2% during the forecast period (2025-2032).

The global carrier screening market is poised for growth, driven by the rising incidence of genetic diseases and an increasing focus on preventive healthcare. Advancements in genomic technologies and heightened awareness of disorders like cystic fibrosis, Tay-Sachs, and sickle cell anemia are expected to enhance the adoption of carrier screening in the coming years. Furthermore, improved accessibility to genetic testing and favorable reimbursement policies present new opportunities for industry players. However, challenges such as a lack of standardization, limited awareness in emerging markets, complexities in result interpretation, and the high costs associated with advanced testing technologies may hinder market progression through 2031. Overall, the landscape is ripe for innovation, but stakeholders must navigate these hurdles to capitalize on growth opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Carrier Screening market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Carrier Screening Market Segments Analysis

Global Carrier Screening Market is segmented by Test Type, Disease Type, Medical Condition, Technology, End User and region. Based on Test Type, the market is segmented into Molecular Screening Test and Biochemical Screening Test. Based on Disease Type, the market is segmented into Cystic Fibrosis, Tay-Sachs, Gaucher Disease, Sickle Cell Disease, Spinal Muscular Atrophy and Other Autosomal Recessive Genetic Disorders. Based on Medical Condition, the market is segmented into Pulmonary Conditions, Hematological Conditions, Neurological Conditions and Others. Based on Technology, the market is segmented into DNA Sequencing, Polymerase Chain Reaction, Microarrays and Others. Based on End User, the market is segmented into Hospitals, Reference Laboratories, Physician Offices and Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Carrier Screening Market

The growing prevalence of genetic disorders acts as a significant catalyst for the Global Carrier Screening market. As more individuals and families become aware of the risks associated with hereditary conditions, the demand for carrier screening tests rises. This heightened awareness drives healthcare providers to prioritize genetic screening as a preventive measure, allowing for informed decision-making and risk assessment. Furthermore, advancements in genetic testing technologies and increasing accessibility to these services contribute to the market's expansion. Ultimately, the high incidence of genetic disorders emphasizes the importance of carrier screening, fostering growth and innovation within the industry.

Restraints in the Global Carrier Screening Market

One of the significant challenges facing the global carrier screening market is the lack of standardization in screening panels. This issue can lead to inconsistencies in test results and interpretations, which may cause confusion among healthcare providers and patients alike. The variability in testing methodologies and panel compositions across different laboratories can hinder the reliability and comparability of results. Additionally, the absence of a unified framework may create barriers to widespread adoption of carrier screening, as stakeholders may be uncertain about the effectiveness and relevance of various screening options. Addressing this lack of standardization is crucial for the market's growth and acceptance.

Market Trends of the Global Carrier Screening Market

The Global Carrier Screening market is witnessing a significant trend towards the integration of digital health solutions, which is poised to enhance patient engagement and streamline the screening process. As companies increasingly adopt digital platforms, the convenience and accessibility of carrier screening services are expected to attract a broader demographic, ultimately driving market growth. This convergence fosters a more personalized healthcare experience, encouraging more individuals to participate in screening initiatives. By leveraging technology, companies can not only expand their operational reach but also refine their service offerings, positioning themselves favorably in a rapidly evolving healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Carrier Screening Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Molecular Screening Test
• Biochemical Screening Test

Global Carrier Screening Market Size by Disease Type & CAGR (2025-2032)

• Market Overview
• Cystic Fibrosis
• Tay-Sachs
• Gaucher Disease
• Sickle Cell Disease
• Spinal Muscular Atrophy
• Other Autosomal Recessive Genetic Disorders

Global Carrier Screening Market Size by Medical Condition & CAGR (2025-2032)

• Market Overview
• Pulmonary Conditions
• Hematological Conditions
• Neurological Conditions
• Others

Global Carrier Screening Market Size by Technology & CAGR (2025-2032)

• Market Overview
• DNA Sequencing
• Polymerase Chain Reaction
• Microarrays
• Others

Global Carrier Screening Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Reference Laboratories
• Physician Offices and Clinics
• Others

Global Carrier Screening Market Size & CAGR (2025-2032)

• North America (Test Type, Disease Type, Medical Condition, Technology, End User)
  • US
  • Canada
• Europe (Test Type, Disease Type, Medical Condition, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Disease Type, Medical Condition, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Disease Type, Medical Condition, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Disease Type, Medical Condition, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natera, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings (LabCorp) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invitae Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fulgent Genetics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genomics England (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Centogene AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated DNA Technologies, Inc. (IDT) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Genomics (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ambry Genetics Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DNA Genotek Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneDx, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedGenome Labs Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations